Omar Duramad

Title: Innovations of Omar Duramad

Introduction

Omar Duramad is a notable inventor based in Berkeley, California. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that target specific cells.

Latest Patents

Omar holds a patent for "Multimeric bispecific binding molecules specific for CD20 and CD3." This patent discloses pentameric and hexameric CD20 binding molecules and outlines methods for using these molecules to direct complement-mediated, T-cell-mediated, or both types of killing of CD20-expressing cells. His innovative work has the potential to advance therapeutic strategies in treating diseases related to CD20-expressing cells.

Career Highlights

Omar is currently employed at Igm Biosciences, Inc., where he continues to push the boundaries of scientific research and innovation. His work at the company focuses on developing novel therapeutic solutions that leverage his expertise in binding molecules.

Collaborations

Omar collaborates with esteemed colleagues, including Bruce Alan Keyt and Beatrice Tien-Yi Wang. These partnerships enhance the research and development efforts at Igm Biosciences, Inc., fostering an environment of innovation and discovery.

Conclusion

Omar Duramad's contributions to biotechnology through his patent and work at Igm Biosciences, Inc. exemplify the impact of innovative thinking in the field. His dedication to advancing therapeutic solutions highlights the importance of collaboration and research in driving progress.